Enzolytics Inc.
ENZC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,227 | $51,188 | $104,157 | $193,058 |
| - Cash | $0 | $15 | $554 | $2,282 |
| + Debt | $996 | $996 | $1,179 | $1,351 |
| Enterprise Value | $2,224 | $52,170 | $104,782 | $192,126 |
| Revenue | $0 | $53 | $0 | $200 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | -$22 | $31 | -$22 | $183 |
| % Margin | – | 58.2% | – | 91.5% |
| EBITDA | -$335 | -$2,122 | -$2,882 | -$612 |
| % Margin | – | -4,019.3% | – | -306% |
| Net Income | -$394 | -$2,177 | -$2,941 | -$669 |
| % Margin | – | -4,123.1% | – | -334.5% |
| EPS Diluted | -0 | -0.001 | -0.001 | -0 |
| % Growth | 57.1% | 30% | -400% | – |
| Operating Cash Flow | -$563 | -$880 | -$2,661 | -$1,306 |
| Capital Expenditures | $0 | -$0 | $0 | -$166 |
| Free Cash Flow | -$563 | -$880 | -$2,661 | -$1,472 |